OpenAlex
PricingAboutJobs
Log inGet started
Work

Cutaneous manifestations of dabrafenib (GSK2118436): a selective inhibitor of mutant BRAF in patients with metastatic melanoma

HTML

Year: 2012
Type: article
Source: British Journal of Dermatology
DOI: 10.1111/j.1365-2133.2012.11155.x
Authors: R.M. Anforth, T.C.M.P. Blumetti, R.F. Kefford, R. Sharma, R.A. Scolyer, S. Kossard, G.V. Long, P. Fernandez-Peñas
Institutions: The University of Sydney, Westmead Hospital, Melanoma Institute Australia, Westmead Institute, Western Sydney University, Royal Prince Alfred Hospital, Skin and Cancer Foundation
Language: English

Topic: Chemotherapy-related skin toxicity
Subfield: Dermatology
Field: Medicine
Domain: Health Sciences
Keywords: dabrafenib, BRAF inhibitors, drug-induced skin reaction, metastatic melanoma, squamous cell carcinoma, Grover's disease, keratoacanthoma, p16 immunohistochemistry, human papillomavirus, seborrheic keratosis, drug-induced skin toxicity
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W1506082933
FWCI: 31.95
Cites: 33
Cited by: 179
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms